Small Molecule Innovator CDMO Market Set For Heavy Growth
According to insights, the market for contract development and manufacturing organizations (CDMOs) specializing in small molecule innovation is estimated to reach a value of...
Pharma Sterility Testing Market Set For Remarkable Growth
Recent insights suggest that the pharmaceutical sterility testing market is projected to grow from $0.636 billion in 2023 to $1.0223 billion by 2032. Factors...
CU Medicine Reveals That Neutrophils Can Combat Lung Cancer
In Hong Kong, lung cancer continues to be the most prevalent form of cancer. Despite its status as a prominent global cause of cancer-related...
Inexperience Makes CDMOs Struggle With Cell And Gene Therapy
CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of companies preparing to scale up their cell and gene...
$85bn M&A Splurge Helps In Big Pharma Dealmaking Recovery
It is well to be noted that pharma and biotech companies splurged a whopping $85 billion in the first five months of 2023, which...
FDA Releases Draft Guidance On Digital Health Technologies
The US Food and Drug Administration has released a draft guidance on good clinical practices (GCPs) to improve the design and implementation of clinical...
Researchers Utilize AI To Combat Drug-Resistant Bacterium
McMaster University and Massachusetts Institute of Technology scientists leverage artificial intelligence to uncover a novel antibiotic named abaucin. This breakthrough has the potential to...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...